Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.norrispharma.com | |
Market Cap | 12.19 Cr. | |
Enterprise Value(EV) | 33.73 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -1.91 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 42.26 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | -13.73 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | -0.89 | Calculated using Price: 12.19 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.00 Cr. | 10,000,700 Shares |
FaceValue | 10 | |
About Norris Medicines Ltd. | ||
The business area of the company is manufacturing of Injections and Medicinal formulations. |
1 Day |
|
|
1 Week |
|
-3.79% |
1 Month |
|
-15.05% |
3 Month |
|
-54.82% |
6 Month |
|
+3.83% |
1 Year |
|
+5.00% |
2 Year |
|
-65.12% |
5 Year |
|
+93.49% |
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -17.93 | 0.71 | -15.52 | -76.01 | -138.44 | 0 | 0 | 0 | 0 | |
Return on Capital Employed (%) | 3.99 | 4.06 | -4.06 | -17.04 | -9.18 | -18.63 | -17.87 | -6.59 | 3.17 | |
Return on Assets (%) | -5.8 | 0.23 | -4.18 | -13.07 | -9.37 | -16.48 | -29.19 | -21.99 | -13.88 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 5 | 5 | 5 | 2 | 0 | -2 | -7 | -11 | -12 | -14 | |
Non Curr. Liab. | 6 | 6 | 6 | 5 | 8 | 11 | 13 | 16 | 17 | 19 | |
Curr. Liab. | 5 | 5 | 10 | 11 | 9 | 8 | 12 | 7 | 8 | 8 | |
Minority Int. | |||||||||||
Equity & Liab. | 17 | 17 | 20 | 18 | 18 | 17 | 17 | 13 | 13 | 13 | |
Non Curr. Assets | 10 | 10 | 11 | 11 | 10 | 9 | 9 | 8 | 8 | 8 | |
Curr. Assets | 7 | 7 | 9 | 8 | 7 | 7 | 8 | 4 | 5 | 5 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 17 | 17 | 20 | 18 | 18 | 17 | 17 | 13 | 13 | 13 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 19 | 19 | 20 | 14 | 16 | 8 | 12 | 9 | 8 | 5 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Income | 19 | 19 | 21 | 14 | 16 | 8 | 12 | 9 | 8 | 5 | |
Total Expenditure | -17 | -18 | -21 | -15 | -17 | -10 | -14 | -10 | -7 | -5 | |
PBIDT | 2 | 1 | 0 | -2 | -1 | -2 | -2 | 0 | 1 | 0 | |
Interest | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -1 | -2 | -1 | |
Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
Taxation | -1 | 0 | 0 | 1 | 0 | 1 | -1 | -1 | -1 | -1 | |
Exceptional Items | |||||||||||
PAT | -1 | 0 | -1 | -3 | -2 | -3 | -5 | -3 | -2 | -2 | |
Adjusted EPS | -1 | 0 | -1 | -3 | -2 | -3 | -5 | -3 | -2 | -2 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 1 | 1 | 1 | -1 | 1 | -2 | -3 | 1 | -1 | 1 | |
Cash Fr. Inv. | -2 | -1 | 0 | -2 | 0 | 0 | 0 | 0 | 0 | ||
Cash Fr. Finan. | 0 | 0 | -1 | 3 | -1 | 2 | 3 | -1 | 1 | -1 | |
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Mon, 29 Apr 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On 29Th April 2024 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 As per attachment |
Sat, 27 Apr 2024
Compliance Certificate As Per Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Year Ended 31St March 2024. As per attachment. |
Wed, 24 Apr 2024
Compliance Certificate Pursuant To Regulation 7 (3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As per attachment. |
Mon, 06 May 2024 |
Higher Delivery Quantity |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |
Opening at High |
Opening at Low |